Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2008
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269120 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
10/30/2008US20080269115 Immunogenic Sars Domain
10/30/2008US20080269114 Y4 Selective Receptor Agonists For Thereapeutic Interventions
10/30/2008US20080269113 P53 binding t cell receptor molecules
10/30/2008US20080269074 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation
10/30/2008US20080268523 Using vector transformation to generate transgenic organism which can express heterologous protein in high and low temperatures
10/30/2008US20080268522 Lentiviral packaging constructs
10/30/2008US20080268520 Compositions and methods for recombinational cloning of nucleic acid molecules
10/30/2008US20080268519 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides
10/30/2008US20080268518 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
10/30/2008US20080268505 Preparing preferential nucleotide sequences via DNA repair and heteroduplex conversion; directed protein evolution
10/30/2008US20080268501 Methods and materials relating to gene expression
10/30/2008US20080268499 Nucleotide sequences coding hormone recptors for use in identifying modulaors of insect propagation; biological pest control; insecticides
10/30/2008US20080268489 Therapeutic polypeptide for use in treatment of heart, hypothermic and cardiovascular disorders
10/30/2008US20080268476 Nectin 4 (N4) as a Marker for Cancer Prognosis
10/30/2008US20080268475 Transgenic saccharomyces comprising orphan receptors for use in monitor drug binding affinities; drug screening
10/30/2008US20080268474 Prion protein ligands and methods of use
10/30/2008US20080268438 Model system for identifying anti-cancer agents
10/30/2008US20080268424 Glut-1 as a Receptor for Htlv Envelopes and its Uses
10/30/2008US20080268287 Method of Converting Water-Soluble Active Proteins Into Hydrophobic Active Proteins, the Use of the Same for the Preparation of Monomolecular Layers of Oriented Active Proteins, and Devices Comprising the Same
10/30/2008US20080268030 Gene therapy for diabetic ischemic disease
10/30/2008US20080268029 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases
10/30/2008US20080268015 Methods and compositions for promoting localization of pharmaceutically active agents to bone
10/30/2008US20080267993 Administering Human Immunodeficiency Virus type 1 Envelope (env) sequence having a first set of consensus glycosylation sequences, followed by a second immunogen comprising a primate immunodeficiency virus env sequence having a second set of consensus glycosylation sequences
10/30/2008US20080267990 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection
10/30/2008US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection
10/30/2008US20080267987 Major histocompatibility complex polypeptide for use in targeting, detecting and purifying antigen-specific T-cells; for treatment and prevention of inflammatory, arthritic and autoimmune disease
10/30/2008US20080267985 Major allergen Phl p 1 comprising reduced immunoglobulin reactivity for use in treating grass pollen allergies; immunotherapy
10/30/2008US20080267983 Mimetic peptide for use in treatment and prevention of stroke, cardiovascular, neurodegenerative, inflammatory and vision defects
10/30/2008US20080267980 Complement Receptor 2 Targeted Complement Modulators
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267966 Polypeptides from Non-Typeable Haemophilus Influenzae
10/30/2008US20080267965 Use of Bcma as an Immunoregulatory Agent
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267958 Lymphatic endothelial glycoprotein for use as tool in identifying modulators for prevention and treatment of inflammation and cell proliferative disorders
10/30/2008US20080267949 Peptides capable of binding to serum proteins
10/30/2008US20080267944 Expression vector comprising nucleotide sequences coding serine potease like protein for use in depleting fibrinogen from blood and diagnosing dysprothrombinemias
10/30/2008US20080267940 Using protamine to precipitate fibrinogen from whole blood; wound healing agent
10/30/2008US20080267930 Biological Materials and Uses Thereof
10/30/2008US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders
10/30/2008US20080267908 Using alteration in interleukin-32 binding to proteinase-3 to identify compounds which maybe useful in treatment of inflammatory disorders
10/30/2008US20080267887 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits
10/30/2008US20080267882 Multimeric RGD (arginine-glycine-aspartic acid (Arg-Gly-Asp)) peptide; positron emission tomography; angiogenesis; kits
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008US20080267863 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Colon Cancer
10/30/2008US20080265206 Enzymatic conversion of 5-norbornene-2-carbonitrile to give 5-norbornene-2-carboxylic acid with a high substrate concentration; nucleic acid encoding said polypeptide; suitable for preparation of cyclic olefin copolymers, pharmaceutical intermediates, pesticides or fragrances
10/30/2008CA2689481A1 Engineered versions of cgtb (.beta.-1,3-galactosyltransferase) enzymes, with enhanced enzymatic properties
10/30/2008CA2684834A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008CA2684707A1 Mo-1, a gene associated with morbid obesity
10/30/2008CA2684650A1 Expression system
10/30/2008CA2684575A1 Modified plant defensin
10/30/2008CA2684555A1 Use of hemagglutinin of the african swine fever virus as an adjuvant
10/30/2008CA2684330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008CA2684329A1 Identification and method for using the pre-ligand assembly domain of the il-17 receptor
10/30/2008CA2684278A1 Method for inhibiting scavenger receptor-a and increasing immune response to antigens
10/30/2008CA2683789A1 Corn plants and seed enhanced for asparagine and protein
10/30/2008CA2683083A1 Methods of diagnosing alzheimer's disease and markers identified by set association
10/30/2008CA2683078A1 Asparaginase enzyme variants and uses thereof
10/30/2008CA2682677A1 Novel asparaginases and uses thereof
10/30/2008CA2680487A1 Peptide mixture as wine stabiliser
10/30/2008CA2680396A1 Mannoprotein liquid formulations
10/30/2008CA2678190A1 Novel viii factors for the treatment of type a hemophilia
10/30/2008CA2677734A1 (3r)-hydroxyacyl-acp dehydratase enzymes used in the biosynthesis of mycolic acids and use of same for screening antibiotics
10/29/2008EP1986009A1 Screening method
10/29/2008EP1985711A1 Method for efficient purification of bionanocapsule
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985705A2 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985701A2 Genes differentially expressed in breast cancer
10/29/2008EP1985699A1 Controlled dissolution crosslinked protein crystals
10/29/2008EP1985631A1 Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A
10/29/2008EP1985630A2 T1R taste receptors and genes encoding same
10/29/2008EP1985629A1 Pro-apoptotic molecules and therapeutic uses thereof
10/29/2008EP1985628A1 Bis-met histones
10/29/2008EP1985627A1 Putative chloroplast transporter as novel specific kanamycin resistance marker
10/29/2008EP1985626A1 P. gingivalis antigenic composition
10/29/2008EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis
10/29/2008EP1985623A1 Process for producing proteoglycan
10/29/2008EP1985306A2 TRX1 antibody and uses therefor
10/29/2008EP1985304A2 Novel compounds and their effects on feeding behaviour
10/29/2008EP1985302A1 Medicament for treatment of tumor and the use thereof
10/29/2008EP1985293A1 Method for producing denatured substance of lactalbumin
10/29/2008EP1984736A2 Cd86 and cd80 receptor competition assays
10/29/2008EP1984546A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects
10/29/2008EP1984523A2 Mutant jak3 kinase in human leukemia
10/29/2008EP1984522A2 Methods of increasing lymphatic function
10/29/2008EP1984504A2 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
10/29/2008EP1984503A1 Modified coagulation factor vila with extended half-life
10/29/2008EP1984405A2 Influenza antigens, vaccine compositions, and related methods
10/29/2008EP1984398A1 Composition and method to increase mammalian sperm function
10/29/2008EP1984397A2 Vegf variants
10/29/2008EP1984396A2 Inhibitors specific of presenilin-1 and their uses
10/29/2008EP1984395A2 Modulation of bone formation
10/29/2008EP1984394A1 Method for immunoadsorption by means of autoantigens
10/29/2008EP1984393A2 Apoptosis methods, genes and proteins
10/29/2008EP1984392A1 Novel cc-chemokine antagonists
10/29/2008EP1984391A1 Pharmaceutical composition for treating vascular-related diseases comprising peptide
1 ... 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 ... 2916